Scribe Therapeutics Inc. SCTX · Insights

website

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-b...

Price16.68

Market Cap269.92 M

Float1.7 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro